You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Maintaining Digestive Health in Diabetes: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Vivi Li and Version 1 by Theodoros Varzakas.

Over the last decades, the incidence of diabetes has increased in developed countries and beyond the genetic impact, environmental factors, which can trigger the activation of the gut immune system, seem to affect the induction of the disease process. Since the composition of the gut microbiome might disturb the normal interaction with the immune system and contribute to altered immune responses, the restoration of normal microbiota composition constitutes a new target for the prevention and treatment of diabetes. Thus, the interaction of gut microbiome and diabetes, focusing on mechanisms connecting gut microbiota with the occurrence of the disorder, is discussed in the present review. Finally, the challenge of functional food diet on maintaining intestinal health and microbial flora diversity and functionality, as a potential tool for the onset inhibition and management of the disease, is highlighted by reporting key animal studies and clinical trials. Early onset of the disease in the oral cavity is an important factor for the incorporation of a functional food diet in daily routine.

  • diabetes
  • fermented foods
  • functional foods
  • gut microbiome
  • digestive health
  • nutrition
  • probiotics
  • prebiotics
Please wait, diff process is still running!

References

  1. World Health Organization. Diabetes. Available online: (accessed on 19 November 2020).
  2. International Diabetes Federation. Facts and Figures. Available online: (accessed on 26 December 2020).
  3. Petersen, M.C.; Shulman, G.I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 2018, 98, 2133–2223.
  4. Guo, C.; Chen, W.D.; Wang, Y.D. TGR5, Not only a metabolic regulator. Front. Physiol. 2016, 7, 646.
  5. WebMD. Types of Diabetes Mellitus. Available online: (accessed on 19 November 2020).
  6. Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539–553.
  7. Hasain, Z.; Mokhtar, N.M.; Kamaruddin, N.A.; Ismail, N.A.M.; Razalli, N.H.; Gnanou, J.V.; Ali, R.A.R. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential. Front. Cell. Infect. Microbiol. 2020, 10, 188.
  8. Bellamy, L.; Casas, J.P.; Hingorani, A.D.; Williams, D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009, 373, 1773–1779.
  9. Boulangé, C.L.; Neves, A.L.; Chilloux, J.; Nicholson, J.K.; Dumas, M.E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016, 8, 42.
  10. Sell, H.; Habich, C.; Eckel, J. Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 2012, 8, 709–716.
  11. Yoon, J.W.; Jun, H.S. Autoimmune destruction of pancreatic beta cells. Am. J. Ther. 2005, 12, 580–591.
  12. Karlsson, F.A.; Berne, C.; Björk, E.; Kullin, M.; Li, Z.; Ma, J.Y.; Schölin, A.; Zhao, L. Beta-cell activity and destruction in type 1 diabetes. Ups. J. Med. Sci. 2000, 105, 85–95.
  13. Filippi, C.M.; von Herrath, M.G. Viral trigger for type 1 diabetes: Pros and cons. Diabetes 2008, 57, 2863–2871.
  14. Beik, P.; Ciesielska, M.; Kucza, M.; Kurczewska, A.; Kuźmińska, J.; Maćkowiak, B.; Niechciał, E. Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities. J. Clin. Med. 2020, 9, 2805.
  15. Stefanaki, C.; Peppa, M.; Mastorakos, G.; Chrousos, G.P. Examining the gut bacteriome, virome, and mycobiome in glucose metabolism disorders: Are we on the right track? Metab. Clin. Exp. 2017, 73, 52–66.
  16. World Health Organization. Global Report on Diabetes. Available online: (accessed on 19 November 2020).
  17. Mauri-Obradors, E.; Estrugo-Devesa, A.; Jané-Salas, E.; Viñas, M.; López-López, J. Oral manifestations of Diabetes Mellitus. A systematic review. Med. Oral. Patol. Oral. Cir. Bucal. 2017, 22, e586–e594.
  18. Connolly, V.; Unwin, N.; Sherriff, P.; Bilous, R.; Kelly, W. Diabetes prevalence and socioeconomic status: A population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J. Epidemiol. Community Health 2000, 54, 173–177.
  19. Rayappa, Ph.; Raju, K.; Kapur, A.; Björk, S.; Sylvest, C.; Kumar, D. The Impact of socio-economic factors on diabetes care. Int. J. Diab. Dev. Ctries. 1999, 19, 7–15.
  20. Anjana, R.M.; Deepa, M.; Pradeepa, R.; Mahanta, J.; Narain, K.; Das, H.K.; Adhikari, P.; Rao, P.V.; Saboo, B.; Kumar, A.; et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017, 5, 585–596.
  21. Statista. Prevalence of Diabetes in Europe in 2019. Available online: (accessed on 19 November 2020).
  22. Monjiote, D.P.; Leo, E.E.M.; Campos, M.R.S. Functional and Biological Potential of Bioactive Compounds in Foods for the Dietary Treatment of Type 2 Diabetes Mellitus. Functional Food—Improve Health through Adequate Food; Hueda, M.C., Ed.; IntechOpen: London, UK, 2017.
  23. Mancebo, F. Urbanism. In Encyclopedia of Community: From the Village to the Virtual World; Sage: New York, NY, USA, 2003; pp. 1428–1433.
  24. Stavropoulou, E.; Tsigalou, C.; Bezirtzoglou, E. Functions of the Human Intestinal Microbiota in Relation to Functional Foods. Erciyes Med. J. 2018, 40, 188–193.
  25. Bezirtzoglou, E.; Stavropoulou, E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe 2011, 17, 369–374.
  26. Food & Nutrition Magazine. The History and Health Benefits of Fermented Food. Available online: (accessed on 29 November 2020).
  27. Smid, E.J.; Hugenholtz, J. Functional Genomics for Food Fermentation Processes. Annu. Rev. Food Sci. Technol. 2010, 1, 497–519.
  28. Montet, D.; Ray, R. Fermented Foods: Part I: Biochemistry & Biotechnology. Fermented Foods; Routledge: Abingdon, UK, 2015.
  29. Adesulu-Dahunsi, A.T.; Dahunsi, S.O.; Olayanju, A. Synergistic microbial interactions between lactic acid bacteria and yeasts during production of Nigerian indigenous fermented foods and beverages. Food Control 2020, 110, 106963.
  30. Stavropoulou, E.; Bezirtzoglou, E. Probiotics in Medicine: A Long Debate. Front. Immunol. 2020, 11, 2192.
  31. Stavropoulou, E.; Bezirtzoglou, E. Probiotics as a weapon in the fight against COVID-19. Front. Nutr. 2020, 7, 614986.
  32. Elbron, J.S. Cystic fibrosis. Lancet 2016, 388, 2519–2531.
  33. Iwatani, S.; Yamamoto, N. Functional food products in Japan: A review. Food Sci. Hum. Well. 2019, 8, 96–101.
  34. Nutraceutical and Functional Food Regulations in the United States and around the World; Elsevier: Amsterdam, The Netherlands, 2019.
  35. Fukushima, Y.; Kawata, Y.; Hara, H.; Terada, A.; Mitsuoka, T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 1998, 42, 39–44.
  36. Küster-Boluda, I.; Vidal-Capilla, I. Consumer attitudes in the election of functional foods. Spanish J. Mark. ESIC 2017, 21, 65–79.
  37. Steinhagen, F.; Schmidt, S.V.; Schewe, J.C.; Peukert, K.; Klinman, D.M.; Bode, C. Immunotherapy in sepsis—Brake or accelerate? Pharmacol. Ther. 2020, 208, 107476.
  38. Mirmiran, P.; Bahadoran, Z.; Azizi, F. Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review. World J. Diabetes 2014, 5, 267–281.
  39. Alkhatib, A.; Tsang, C.; Tiss, A.; Bahorun, T.; Arefanian, H.; Barake, R. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management. Nutrients 2017, 9, 1310.
  40. Tsigalou, C.; Konstantinidis, T.; Paraschaki, A.; Stavropoulou, E.; Voidarou, C.; Bezirtzoglou, E. Mediterranean Diet as a Tool to Combat Inflammation and Chronic Diseases. An Overview. Biomedicines 2020, 8, 201.
  41. GMFH—Best of Nutrition Diet. Available online: (accessed on 29 November 2020).
  42. Tomova, A.; Bukovsky, I.; Rembert, E.; Yonas, W.; Alwarith, J.; Barnard, N.; Kahleova, H. The Effects of Vegetarian and Vegan Diets on Gut Microbiota. Front. Nutr. 2019, 6, 47.
  43. Tonucci, L.B.; Dos Santos, K.M.O.; Ferreira, C.L.D.L.F.; Ribeiro, S.M.R.; De Oliveira, L.L.; Martino, H.S.D. Gut microbiota and probiotics: Focus on diabetes mellitus. Crit. Rev. Food Sci. Nutr. 2017, 57, 2296–2309.
  44. Yao, K.; Zeng, L.; He, Q.; Wang, W.; Lei, J.; Zou, X. Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials. Med. Sci. Monit. 2017, 23, 3044–3053.
  45. Honda, K.; Moto, M.; Uchida, N.; He, F.; Hashizume, N. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J. Clin. Biochem. Nutr. 2012, 51, 96–101.
  46. Silva, J.C.P.; Jones, J.G. Improving Metabolic Control Through Functional Foods. Curr. Med. Chem. 2020, 26, 3424–3438.
  47. Kerry, R.G.; Das, G.; Golla, U.; Rodriguez-Torres, M.D.; Shin, H.; Patra, J.K. Engineered probiotic and prebiotic nutraceutical supplementations in combating non-communicable disorders: A review. Curr. Pharm. Biotechnol. 2020, 21, 33050862.
  48. King, A.J. The use of animal models in diabetes research. Br. J. Pharmacol. 2012, 166, 877–894.
  49. Al-Awar, A.; Kupai, K.; Veszelka, M.; Szucs, G.; Attieh, Z.; Murlasits, Z.; Varga, C. Experimental Diabetes Mellitus in Different Animal Models. J. Diabetes Res. 2016, 2016, 9051426.
  50. Xue, M.; Liua, Y.; Xu, H.; Zhou, Z.; Ma, Y.; Sun, T.; Liu, M.; Zhang, H.; Liang, H. Propolis modulates the gut microbiota and improves the intestinal mucosal barrier function in diabetic rats. Biomed. Pharmacother. 2019, 118, 109393.
  51. Terzo, S.; Mulè, F.; Caldara, G.F.; Baldassano, S.; Puleio, R.; Vitale, M.; Cassata, G.; Ferrantelli, V.; Amato, A. Pistachio Consumption Alleviates Inflammation and Improves Gut Microbiota Composition in Mice Fed a High-Fat Diet. Int. J. Mol. Sci. 2020, 21, 365.
  52. Yanni, AE.; Mitropoulou, G.; Prapa, I.; Agrogiannis, G.; Kostomitsopoulos, N.; Bezirtzoglou, E.; Kourkoutas, Y.; Karathanos, V.T. Functional modulation of gut microbiota in diabetic rats following dietary intervention with pistachio nuts (Pistacia vera L.). Metab. Open 2020, 7, 100040.
  53. Zhong, Y.; Nyman, M.; Fak, F. Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol. Nutr. Food Res. 2015, 59, 2066–2076.
  54. Bhandarkar, N.S.; Brown, L.; Panchal, S.K. Chlorogenic acid attenuates high-carbohydrate, high-fat diet-induced cardiovascular, liver, and metabolic changes in rats. Nutr. Res. 2018, 62, 78–88.
  55. Zhang, H.H.; Liu, J.; Lv, Y.J.; Jiang, Y.I.; Pan, J.X.; Zhu, Y.J.; Huang, M.G.; Zhang, S.K. Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha. Can. J. Diabetes 2020, 44, 44–52.
  56. Surono, I.S.; Wardana, A.A.; Waspodo, P.; Saksono, B.; Verhoeven, J.; Venema, K. Effect of functional food ingredients on gut microbiota in a rodent diabetes model. Nutr. Metab. 2020, 17, 77.
  57. Sane, F.; Scuotto, A.; Pierrat, V.; Kacet, N.; Hober, D.; Romond, M.B. Diabetes progression and alterations in gut bacterial translocation: Prevention by diet supplementation with human milk in NOD mice. J. Nutr. Biochem. 2018, 62, 108–122.
  58. Shikano, A.; Kuda, T.; Shibayama, J.; Toyama, A.; Ishida, Y.; Takahashi, H.; Kimura, B. Effects of lactobacillus plantarum uruma-SU4 fermented green loofah on plasma lipid levels and gut microbiome of high-fat diet fed mice. Food Res. Int. 2019, 121, 817–824.
  59. Singh, S.; Sharma, R.K.; Malhotra, S.; Pothuraju, R.; Shandilya, U.K. Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocin treated rats. Benef. Microbes 2017, 8, 243–255.
  60. Cabello-Olmo, Μ.; Oneca, Μ.; Torre, P.; Sainz, N.; Moreno-Aliaga, M.J.; Guruceaga, E.; Díaz, J.V.; Encio, I.J.; Barajas, M.; Araña, M. A Fermented Food Product Containing Lactic Acid Bacteria Protects ZDF Rats from the Development of Type 2 Diabetes. Nutrients 2019, 11, 2530.
  61. Hu, T.G.; Wen, P.; Shen, W.Z.; Liu, F.; Li, Q.; Li, E.N.; Liao, S.T.; Wu, H.; Zou, Y.X. Effect of 1-Deoxynojirimycin Isolated from Mulberry Leaves on Glucose Metabolism and Gut Microbiota in a Streptozotocin-Induced Diabetic Mouse Model. J. Nat. Prod. 2019, 82, 2189–2200.
  62. Shah, N.J.; Swami, O.C. Role of probiotics in diabetes: A review of their rationale and efficacy. EMJ Diabet. 2017, 5, 104–110.
  63. Dolpady, J.; Sorini, C.; Di Pietro, C.; Cosorich, I.; Ferrarese, R.; Saita, D.; Clementi, M.; Canducci, F.; Falcone, M. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. J. Diabetes Res. 2016, 2016, 7569431.
  64. Morshedi, M.; Saghafi-Asl, M.; Hosseinifard, E.S. The potential therapeutic effects of the gut microbiome manipulation by symbiotic containing-Lactobacillus plantarum on neuropsychological performance of diabetic rats. Transl. Med. 2020. 18, 1–14.
  65. Farida, E.; Nuraida, L.; Giriwono, P.E.; Jenie, B.L.E. Lactobacillus rhamnosus Reduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats. International Journal of Food Science 2020, 2020, 6108575.
  66. Tian, P.; Li, B.; He, C.; Song, W.; Hou, A.; Tian, S.; Meng, X.; Lia, K.; Shan, Y. Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota. Food Funct. 2016, 7, 3789–3797.
  67. Li, K.K.; Tian, P.J.; Wang, S.D.; Lei, P.; Qu, L.; Huang, J.P.; Shan, Y.J.; Li, B.L. Targeting gut microbiota: Lactobacillus alleviated type 2 diabetes via inhibiting LPS secretion and activating GPR43 pathway. J. Funct. Foods 2017, 38, 561–570.
  68. Li, X.; Wang, E.; Yin, B.; Fang, D.; Chen, P.; Wang, G.; Zhao, J.; Zhang, H.; Chen, W. Effects of Lactobacillus casei CCFM419 on insulin resistance and gut microbiota in type 2 diabetic mice. Benef 2017, 8, 421–432.
  69. Zhang, Y.; Guo, X.; Guo, J.; He, Q.; Li, H.; Song, Y.; Zang, H. Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci. Rep. 2014, 4, 5654.
  70. Wang, G.; Li, X.; Zhao, J.; Zhang, H.; Chen, W. Lactobacillus casei CCFM419 attenuated type 2 diabetes via a gut microbiota dependent mechanism. Food Funct. 2017, 8, 3155–3164.
  71. Allen, S.J.; Jordan, S.; Storey, M.; Thornton, C.A.; Gravenor, M.; Garaiova, I.; Plummer, S.F.; Wang, D.; Morgan, G. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J. Nutr. 2010, 140, 483–488.
  72. Kassaian, N.; Feizi, A.; Aminorroaya, A.; Amini, M. Probiotic and synbiotic supplementation could improve metabolic syndrome in prediabetic adults: A randomized controlled trial. Diabetes Metab. Syndr. 2019, 13, 2991–2996.
  73. Khalili, L.; Alipour, B.; Jafar-Abadi, M.A.; Faraji, I.; Hassanalilou, T.; Mesgari Abbasi, M.; Vaghef-Mehrabany, E.; Sani, A.M. The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Iran Biomed. J. 2019, 23, 68–77.
  74. Medina-Vera, I.; Sanchez-Tapia, M.; Noriega-López, L.; Granados-Portillo, O.; Guevara-Cruz, M.; Flores-López, A.; Avila-Nava, A.; Fernández, M.L.; Tovar, A.R.; Torres, N. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes. Diabetes Metab. 2019, 45, 122–131.
  75. Sabico, S.; Al-Mashharawi, A.; Al-Daghri, N.M.; Wani, K.; Amer, O.E.; Hussain, D.S.; Ansari, A.M.G.; Masoud, M.S.; Alokail, M.S.; McTernan, P.G. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2019, 38, 1561–1569.
  76. Sato, J.; Kanazawa, A.; Azuma, K.; Ikeda, F.; Goto, H.; Komiya, K.; Kanno, R.; Tamura, Y.; Asahara, T.; Takahashi, T.; et al. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study. Sci. Rep. 2017, 7, 12115.
  77. Tonucci, L.B.; Dos Santos, O.K.M.; de Oliveira, L.L.; Ribeiro, R.S.M.; Martino, D.H.S. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin. Nutr. 2017, 36, 85–92.
  78. Yanni, A.E.; Kartsioti, K.; Karathanos, V.T. The role of yogurt consumption in the management of type 2 diabetes. Food Funct. 2020, 11, 10306–10316.
  79. Ejtahed, H.S.; Mohtadi-Nia, J.; Homayouni-Rad, A.; Niafar, M.; Asghari-Jafarabadi, M.; Mofid, V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28, 539–543.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Academic Video Service
Feedback